Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-26-069604
Filing Date
2026-06-02
Accepted
2026-06-02 18:56:16
Documents
1
Period of Report
2026-05-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2616591-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2616591-1_4seq1.xml 4 3962
  Complete submission text file 0001104659-26-069604.txt   5646
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Issuer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PHIBRO ANIMAL HEALTH CORP GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 F TEANECK NJ 07666
Business Address
CORCORAN E THOMAS (Reporting) CIK: 0001191763 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36410 | Film No.: 261058335